Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cyclacel Pharmaceuticals Inc. buy Roth Mkm

Start price
€0.22
03.05.24 / 50%
Target price
€10.21
03.05.25
Performance (%)
-
End price
-
04.05.25
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Cyclacel Pharmaceuticals Inc. - - -
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by Roth_Mkm for this prediction

In the thread Cyclacel Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 10.208
Change
Ends at 03.05.25

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) had its price target lowered by analysts at Roth Mkm from $21.00 to $11.00. They now have a "buy" rating on the stock.
Ratings data for CYCC provided by MarketBeat

In the thread Trading Cyclacel Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -
Target price 10.208
Change
Ends at 03.05.25

Die von Roth_Mkm gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Roth_Mkm for Cyclacel Pharmaceuticals Inc.

buy
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.22
19.12.23
€19.12
19.12.24
-
20.12.24